Artikelnummer: 937 Kategorien: , Schlüsselwort:


Active ingredient: Nandrolone phenylpropionate.

Nandrolone phenylpropionate, as the name suggests, very similar to the very popular Deca. He – the predecessor of the deck as already in 1959. I got stuck in the market „Organon“ and so he was three years older than Deca. The main difference lies in the different effects of these drugs on the body. The structure nandrolone F comes along with nandrolone finilpropionate also, unlike the deck that contains the active chemical nandrolone decanoate. Fenilver has due to this shorter exposure time, and if enough of a weekly injection decks, the nandrolone F requires frequent and regular injections. The substance nandrolone – phenylpropionate quickly enters the blood and acts in the it for 2-3 days. Athletes hoping for optimal results inject themselves with Durabolin every third day, even better than every two days. The dosage of 50-100 mg per injection, which corresponds to a total of 150-300mg per week.

Effects of receiving Fenilvera

Qualitative but moderate muscle growth. Fenilver increases protein synthesis and reduces its loss.
The improvement of the absorption of amino acids of the intestine.
The performance enhancement performance. According to its properties to increase strength without significant weight gain of injectable nandrolone is a unique drug and is actively used by athletes, skiers, boxers and other athletes who are not interested in excessive muscle building.
Fat burning effect.
Stimulation of collagen synthesis. By forming collagen, ligaments and joints are strengthened. Fenilver also has the ability to stimulate the release of synovial fluid.
Strengthening immunity.
The anti-inflammatory effect.

Side effects:
Side effects occur in very rare cases and in sensitive people. Such phenomena of masculinization in women as hoarseness, deep voice, acne, increased libido is possible, but unlikely to appear at reasonable dosages. Men usually do not have a problem. Reducing the production of testosterone in men is still possible during chronic administration of the drug in high doses, because gonodropinov ejection delay occurs in the pituitary gland.

Zusätzliche Information